Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 2
1963 1
1966 1
1967 1
1969 4
1970 3
1971 2
1972 2
1973 2
1974 7
1975 16
1976 17
1977 5
1978 31
1979 14
1980 12
1981 19
1982 41
1983 26
1984 37
1985 44
1986 30
1987 28
1988 36
1989 45
1990 57
1991 40
1992 61
1993 74
1994 68
1995 55
1996 90
1997 92
1998 119
1999 132
2000 125
2001 151
2002 136
2003 185
2004 220
2005 247
2006 301
2007 324
2008 326
2009 317
2010 364
2011 373
2012 403
2013 475
2014 420
2015 446
2016 458
2017 467
2018 590
2019 524
2020 505
2021 515
2022 523
2023 435
2024 154

Text availability

Article attribute

Article type

Publication date

Search Results

8,809 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Schizophrenia 8"
Page 1
Current Concepts and Treatments of Schizophrenia.
Stępnicki P, Kondej M, Kaczor AA. Stępnicki P, et al. Molecules. 2018 Aug 20;23(8):2087. doi: 10.3390/molecules23082087. Molecules. 2018. PMID: 30127324 Free PMC article. Review.
Schizophrenia is a debilitating mental illness which involves three groups of symptoms, i.e., positive, negative and cognitive, and has major public health implications. According to various sources, it affects up to 1% of the population. The pathomechanism of schizophr
Schizophrenia is a debilitating mental illness which involves three groups of symptoms, i.e., positive, negative and cognitive, and h
Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016.
Charlson FJ, Ferrari AJ, Santomauro DF, Diminic S, Stockings E, Scott JG, McGrath JJ, Whiteford HA. Charlson FJ, et al. Schizophr Bull. 2018 Oct 17;44(6):1195-1203. doi: 10.1093/schbul/sby058. Schizophr Bull. 2018. PMID: 29762765 Free PMC article. Review.
INTRODUCTION: The global burden of disease (GBD) studies have derived detailed and comparable epidemiological and burden of disease estimates for schizophrenia. We report GBD 2016 estimates of schizophrenia prevalence and burden of disease with disaggregation by age …
INTRODUCTION: The global burden of disease (GBD) studies have derived detailed and comparable epidemiological and burden of disease estimate …
Improving Pleasure and Motivation in Schizophrenia: A Randomized Controlled Clinical Trial.
Favrod J, Nguyen A, Chaix J, Pellet J, Frobert L, Fankhauser C, Ismailaj A, Brana A, Tamic G, Suter C, Rexhaj S, Golay P, Bonsack C. Favrod J, et al. Psychother Psychosom. 2019;88(2):84-95. doi: 10.1159/000496479. Epub 2019 Feb 18. Psychother Psychosom. 2019. PMID: 30783071 Free PMC article. Clinical Trial.
BACKGROUND: Negative symptoms are frequent in patients with schizophrenia and are associated with marked impairments in social functioning. ...METHODS: Eighty participants diagnosed with schizophrenia or schizoaffective disorder were randomized to receive either TAU …
BACKGROUND: Negative symptoms are frequent in patients with schizophrenia and are associated with marked impairments in social functi …
Association between cannabis use disorder and schizophrenia stronger in young males than in females.
Hjorthøj C, Compton W, Starzer M, Nordholm D, Einstein E, Erlangsen A, Nordentoft M, Volkow ND, Han B. Hjorthøj C, et al. Psychol Med. 2023 Nov;53(15):7322-7328. doi: 10.1017/S0033291723000880. Epub 2023 May 4. Psychol Med. 2023. PMID: 37140715 Free PMC article.

During 1972-2021, the annual average percentage change in PARFs for CUD in schizophrenia incidence was 4.8 among males (95% CI 4.3-5.3; p < 0.0001) and 3.2 among females (95% CI 2.5-3.8; p < 0.0001). ...CONCLUSIONS: Young males might be particularly sus

During 1972-2021, the annual average percentage change in PARFs for CUD in schizophrenia incidence was 4.8 among males (95% CI …
Multiple Sclerosis and Schizophrenia.
Arneth BM. Arneth BM. Int J Mol Sci. 2017 Aug 12;18(8):1760. doi: 10.3390/ijms18081760. Int J Mol Sci. 2017. PMID: 28805697 Free PMC article. Review.
This is especially true for patients whose symptoms indicate the coexistence of multiple sclerosis (MS) and schizophrenia (SCZ). These cases raise critical questions regarding the relationship between the mind and the brain. ...
This is especially true for patients whose symptoms indicate the coexistence of multiple sclerosis (MS) and schizophrenia (SCZ). Thes …
New Trends in the Treatment of Schizophrenia.
Meltzer HY. Meltzer HY. CNS Neurol Disord Drug Targets. 2017;16(8):900-906. doi: 10.2174/1871527316666170728165355. CNS Neurol Disord Drug Targets. 2017. PMID: 28758583 Review.
OBJECTIVES: This article are to describe current trends in the treatment of schizophrenia and the most interesting new approaches to optimizing outcome and fostering the development of new schizophrenia treatments. ...Pharmacogenetic efforts are consistent with new …
OBJECTIVES: This article are to describe current trends in the treatment of schizophrenia and the most interesting new approaches to …
Acupuncture for schizophrenia.
Rathbone J, Xia J. Rathbone J, et al. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005475. doi: 10.1002/14651858.CD005475. Cochrane Database Syst Rev. 2005. PMID: 16235404 Updated. Review.
However, the benefits of acupuncture in the treatment of schizophrenia are unclear, and further evidence is needed to inform clinicians and people with schizophrenia of its efficacy in the treatment of schizophrenia. OBJECTIVES: To evaluate acupuncture for pe …
However, the benefits of acupuncture in the treatment of schizophrenia are unclear, and further evidence is needed to inform clinicia …
Relapse in schizophrenia: Definitively not a bolt from the blue.
Spaniel F, Bakstein E, Anyz J, Hlinka J, Sieger T, Hrdlicka J, Görnerová N, Höschl C. Spaniel F, et al. Neurosci Lett. 2018 Mar 16;669:68-74. doi: 10.1016/j.neulet.2016.04.044. Epub 2016 Apr 22. Neurosci Lett. 2018. PMID: 27109788 Review.
EWS history was obtained for 61 relapses resulting in hospitalization involving 51 patients with schizophrenia. Up to 20 weeks of EWS history per case were evaluated using a non-parametric bootstrap test and generalized mixed-effects model to test the significance and homo …
EWS history was obtained for 61 relapses resulting in hospitalization involving 51 patients with schizophrenia. Up to 20 weeks of EWS …
An Overview on the Search for Schizophrenia Biomarkers.
Hallak JE, de Paula AL, Chaves C, Bressan RA, Machado-de-Sousa JP. Hallak JE, et al. CNS Neurol Disord Drug Targets. 2015;14(8):996-1000. doi: 10.2174/1871527314666150909114957. CNS Neurol Disord Drug Targets. 2015. PMID: 26350336 Review.
In this article we describe the main potential schizophrenia markers currently under study and suggest avenues for future research in the field. KEY POINTS: - No reliable markers exist for schizophrenia to date. - The identification of schizophrenia markers c …
In this article we describe the main potential schizophrenia markers currently under study and suggest avenues for future research in …
Predicting and preventing symptom onset and relapse in schizophrenia-A metareview of current empirical evidence.
Lecomte T, Potvin S, Samson C, Francoeur A, Hache-Labelle C, Gagné S, Boucher J, Bouchard M, Mueser KT. Lecomte T, et al. J Abnorm Psychol. 2019 Nov;128(8):840-854. doi: 10.1037/abn0000447. Epub 2019 Jul 25. J Abnorm Psychol. 2019. PMID: 31343181 Review.
Recent meta-analyses covering each component of the model in relation to the onset of psychotic symptoms or symptomatic relapse in schizophrenia were reviewed with the grading of recommendations, assessment, development, and evaluation system. ...
Recent meta-analyses covering each component of the model in relation to the onset of psychotic symptoms or symptomatic relapse in schizo
8,809 results